ZA9610461B - Substituted chromanylsulfony(thio)ureas processes of their preparation their use in pharmaceutical preparations and pharmaceutical preparations comprising them - Google Patents

Substituted chromanylsulfony(thio)ureas processes of their preparation their use in pharmaceutical preparations and pharmaceutical preparations comprising them

Info

Publication number
ZA9610461B
ZA9610461B ZA9610461A ZA9610461A ZA9610461B ZA 9610461 B ZA9610461 B ZA 9610461B ZA 9610461 A ZA9610461 A ZA 9610461A ZA 9610461 A ZA9610461 A ZA 9610461A ZA 9610461 B ZA9610461 B ZA 9610461B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical preparations
chromanylsulfony
ureas
thio
substituted
Prior art date
Application number
ZA9610461A
Other languages
English (en)
Inventor
Heinrich Christian Englert
Uwe Gerlach
Dieter Mania
Wolfgang Linz
Heinz Goegelein
Erik Klaus
Peter Crause
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA9610461B publication Critical patent/ZA9610461B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/56—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/64—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA9610461A 1995-12-14 1996-12-12 Substituted chromanylsulfony(thio)ureas processes of their preparation their use in pharmaceutical preparations and pharmaceutical preparations comprising them ZA9610461B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19546736A DE19546736A1 (de) 1995-12-14 1995-12-14 Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate

Publications (1)

Publication Number Publication Date
ZA9610461B true ZA9610461B (en) 1997-06-17

Family

ID=7780152

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9610461A ZA9610461B (en) 1995-12-14 1996-12-12 Substituted chromanylsulfony(thio)ureas processes of their preparation their use in pharmaceutical preparations and pharmaceutical preparations comprising them

Country Status (29)

Country Link
US (1) US5811448A (cg-RX-API-DMAC10.html)
EP (1) EP0779288B1 (cg-RX-API-DMAC10.html)
JP (1) JP4132115B2 (cg-RX-API-DMAC10.html)
KR (1) KR100460961B1 (cg-RX-API-DMAC10.html)
CN (1) CN1158272C (cg-RX-API-DMAC10.html)
AR (1) AR005249A1 (cg-RX-API-DMAC10.html)
AT (1) ATE191212T1 (cg-RX-API-DMAC10.html)
AU (1) AU707371B2 (cg-RX-API-DMAC10.html)
BR (1) BR9605989A (cg-RX-API-DMAC10.html)
CA (1) CA2192916C (cg-RX-API-DMAC10.html)
CZ (1) CZ291094B6 (cg-RX-API-DMAC10.html)
DE (2) DE19546736A1 (cg-RX-API-DMAC10.html)
DK (1) DK0779288T3 (cg-RX-API-DMAC10.html)
ES (1) ES2146348T3 (cg-RX-API-DMAC10.html)
GR (1) GR3033300T3 (cg-RX-API-DMAC10.html)
HR (1) HRP960584B1 (cg-RX-API-DMAC10.html)
HU (1) HU222284B1 (cg-RX-API-DMAC10.html)
IL (1) IL119822A (cg-RX-API-DMAC10.html)
MY (1) MY115229A (cg-RX-API-DMAC10.html)
NO (1) NO315159B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ299928A (cg-RX-API-DMAC10.html)
PL (1) PL186505B1 (cg-RX-API-DMAC10.html)
PT (1) PT779288E (cg-RX-API-DMAC10.html)
RU (1) RU2170733C2 (cg-RX-API-DMAC10.html)
SI (1) SI0779288T1 (cg-RX-API-DMAC10.html)
SK (1) SK281739B6 (cg-RX-API-DMAC10.html)
TR (1) TR199600992A2 (cg-RX-API-DMAC10.html)
TW (1) TW370528B (cg-RX-API-DMAC10.html)
ZA (1) ZA9610461B (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19647000A1 (de) * 1996-11-14 1998-05-20 Hoechst Ag 3-Amido-chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
FR2756284B1 (fr) * 1996-11-26 2000-04-28 Adir Nouveaux derives du benzopyrane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2830800A (en) * 1999-03-25 2000-10-16 Nissan Chemical Industries Ltd. Chroman derivatives
DE10348298A1 (de) * 2003-10-17 2005-05-19 Solvay Pharmaceuticals Gmbh Amidomethyl-substituierte 2-(4-Sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-ylderivade, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US7368582B2 (en) * 2003-10-17 2008-05-06 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE727417C (de) * 1939-08-23 1942-11-03 Paul Kretzschmar Schwingbackenbrecher
DE1518874C3 (de) * 1964-10-07 1975-03-13 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung
US3803176A (en) * 1969-05-09 1974-04-09 Novo Terapeutisk Labor As Sulfonylurea derivatives
GB1314325A (en) * 1969-05-09 1973-04-18 Novo Teapeutisk Lab As Carboxylic acids
US3780027A (en) * 1970-04-29 1973-12-18 Merck & Co Inc Anthranilic acid derivatives
JP2673024B2 (ja) 1988-01-15 1997-11-05 アボツト・ラボラトリーズ アミノメチル‐クロマン及び‐チオクロマン化合物
US5140039A (en) 1988-01-15 1992-08-18 Abbott Laboratories Aminomethyl-thiochroman compounds
US5185364A (en) 1988-01-15 1993-02-09 Abbott Laboratories Aminomethyl-chroman and -thiochroman compounds
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
TW222637B (cg-RX-API-DMAC10.html) * 1991-12-12 1994-04-21 Hoechst Ag
EP0556674B1 (de) * 1992-02-15 1996-06-19 Hoechst Aktiengesellschaft 3,5-Substituierte Benzoylguanidine, mit antiarrythmischer Wirkung und inhibierender Wirkung auf die Proliferationen von Zellen
CZ284456B6 (cs) * 1992-02-15 1998-12-16 Hoechst Aktiengesellschaft Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje
ATE158278T1 (de) * 1992-02-15 1997-10-15 Hoechst Ag Ortho-substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament
RU2047614C1 (ru) * 1992-06-15 1995-11-10 Джон Вайс энд Бразер Лимитед Гетероциклические соединения, или их фармацевтически приемлемые аддитивные соли кислоты, или n-оксид гетероциклического соединения, или его аддитивная соль кислоты
DK0577024T3 (cg-RX-API-DMAC10.html) * 1992-07-01 1997-02-24 Hoechst Ag
EP0589336B1 (de) * 1992-09-22 1997-01-08 Hoechst Aktiengesellschaft Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika
DK0590455T3 (da) * 1992-09-28 2001-01-22 Hoechst Ag Antiarrytmiske og cardioprotektive substiuerede 1(2H)-isoquinoliner, fremgangsmåde til deres fremstilling, lægemiddel indeh
TW250477B (cg-RX-API-DMAC10.html) * 1992-12-15 1995-07-01 Hoechst Ag
TW250479B (cg-RX-API-DMAC10.html) * 1992-12-15 1995-07-01 Hoechst Ag
ES2100435T3 (es) * 1992-12-16 1997-06-16 Hoechst Ag Aminobenzoilguanidinas 3,5-sustituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene.
EP0604852A1 (de) * 1992-12-28 1994-07-06 Hoechst Aktiengesellschaft 2,4-Substituierte 5-(N-substituierte-Sulfamoyl)-Benzoylguanidine, als Antiarrythmika, Inhibitoren der Proliferationen von Zellen, und Inhibitoren des Natrium-Protonen-Antiporters
DE59403818D1 (de) * 1993-02-20 1997-10-02 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, als Inhibitoren des zellulären Na+/H+-Austauschs oder als Diagnostikum sowie sie enthaltendes Medikament
DE59401361D1 (de) * 1993-02-23 1997-02-06 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe- Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika
IL109570A0 (en) * 1993-05-17 1994-08-26 Fujisawa Pharmaceutical Co Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
DE4318658A1 (de) * 1993-06-04 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4318756A1 (de) * 1993-06-05 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4325822A1 (de) * 1993-07-31 1995-02-02 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EP0639573A1 (de) * 1993-08-03 1995-02-22 Hoechst Aktiengesellschaft Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament
DE4327244A1 (de) * 1993-08-13 1995-02-16 Hoechst Ag Harnstoffsubstituierte Benzoylguandine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4328352A1 (de) * 1993-08-24 1995-03-02 Hoechst Ag Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4328869A1 (de) * 1993-08-27 1995-03-02 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4344550A1 (de) * 1993-12-24 1995-06-29 Hoechst Ag Substituierte 1-Oxo-1,2-dihydro-isochinolinoyl- und 1,1-Dioxo-2H-1,2-benzothiazinoylguanidine, Verfahrenzu ihrer Herstellung, ihre Verwendung als Medikamentt oder Diagnostikum sowie sie enthaltendes Medikamen
TW415937B (en) * 1994-01-25 2000-12-21 Hoechst Ag Phenyl-substituted alkylcarboxylic acid guanidides bearing perfluoroalkyl groups, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
DE4412334A1 (de) * 1994-04-11 1995-10-19 Hoechst Ag Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4415873A1 (de) * 1994-05-05 1995-11-09 Hoechst Ag Substituierte bizyklische Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4417004A1 (de) * 1994-05-13 1995-11-16 Hoechst Ag Perfluoralkyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4421536A1 (de) * 1994-06-20 1995-12-21 Hoechst Ag Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4422685A1 (de) * 1994-06-29 1996-01-04 Hoechst Ag Ortho-amino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4432105A1 (de) * 1994-09-09 1996-03-14 Hoechst Ag Fluoro-alkyl/alkenyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4432106A1 (de) * 1994-09-09 1996-03-14 Hoechst Ag Mit Heterocyclen-N-Oxid-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum, sie enthaltendes Medikament sowie Zwischenprodukte zu ihrer Herstellung
DE4432101A1 (de) * 1994-09-09 1996-03-14 Hoechst Ag Aminosäure-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4441880A1 (de) * 1994-11-24 1996-05-30 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DK0723956T3 (da) * 1995-01-30 2000-04-17 Hoechst Ag Basisk substituerede benzoylguanidiner, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel eller diagnos
HU226462B1 (en) * 1995-02-17 2008-12-29 Hoechst Ag Substituted benzol-sulfonyl-ureas and -thioureas, process for producing them, pharmaceutical compositions containing them, and their use
DE19505397A1 (de) * 1995-02-17 1996-08-22 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
IL119822A0 (en) 1997-03-18
HUP9603450A3 (en) 1998-04-28
GR3033300T3 (en) 2000-09-29
KR100460961B1 (ko) 2006-01-27
HU9603450D0 (en) 1997-02-28
BR9605989A (pt) 1998-08-25
EP0779288A1 (de) 1997-06-18
DE19546736A1 (de) 1997-06-19
CZ365896A3 (en) 1997-07-16
NO315159B1 (no) 2003-07-21
NO965370L (no) 1997-06-16
DE59604831D1 (de) 2000-05-04
CZ291094B6 (cs) 2002-12-11
IL119822A (en) 2000-08-31
SK160296A3 (en) 1997-08-06
RU2170733C2 (ru) 2001-07-20
AR005249A1 (es) 1999-04-28
PL186505B1 (pl) 2004-01-30
DK0779288T3 (da) 2000-07-31
CN1158272C (zh) 2004-07-21
TR199600992A2 (tr) 1997-07-21
TW370528B (en) 1999-09-21
CA2192916A1 (en) 1997-06-15
SI0779288T1 (en) 2000-10-31
HRP960584B1 (en) 2001-02-28
HU222284B1 (hu) 2003-05-28
SK281739B6 (sk) 2001-07-10
NO965370D0 (no) 1996-12-13
AU707371B2 (en) 1999-07-08
HUP9603450A2 (en) 1997-07-28
ATE191212T1 (de) 2000-04-15
AU7531296A (en) 1997-06-19
MX9606397A (es) 1997-10-31
JP4132115B2 (ja) 2008-08-13
ES2146348T3 (es) 2000-08-01
KR970042540A (ko) 1997-07-24
CN1155545A (zh) 1997-07-30
CA2192916C (en) 2006-05-16
HRP960584A2 (en) 1998-02-28
NZ299928A (en) 1998-01-26
JPH09176149A (ja) 1997-07-08
PT779288E (pt) 2000-07-31
MY115229A (en) 2003-04-30
PL317397A1 (en) 1997-06-23
EP0779288B1 (de) 2000-03-29
US5811448A (en) 1998-09-22

Similar Documents

Publication Publication Date Title
HU9303282D0 (en) Pharmaceutical preparations containing hialuronic acid and/or derivatives and/or fragments
IL114578A0 (en) Amino purine-béta-D ribofuranuronamide derivatives their preparation pharmaceutical compositions containing them and their use
HU9303283D0 (en) Pharmaceutical preparations containing hialuronic acid and/or derivatives and/or fragments
ZA956915B (en) Glycinamide derivatives processes for their preparation and medicines containing them
AP9701092A0 (en) Use of fumagilol and derivateves thereof for preparing medicaments against intestinal infections
IL127132A0 (en) Substituted imidazolidine derivatives their preparation their use and pharmaceutical preparations comprising them
EP0686399A4 (en) POWDERED PHARMACEUTICAL PREPARATION AND ITS PRODUCTION PROCESS
IL117349A0 (en) N-(3-benyofuranyl) urea-derivatives their preparation and pharmaceutical compositions containing them
IL114535A0 (en) Urea and thiourea derivatives of azolones their preparation and pharmaceutical compositions containing them
HUP9603071A2 (en) Purin-6-one derivatives and pharmaceuticals preparations containing them
IL123611A0 (en) Novel amino acid derivatives their preparation and use
IL119316A0 (en) Hydroxypyridinones their preparation and pharmaceutical compositions containing them
AU650261B2 (en) Derivatives of glycinamide, their preparation and medicaments containing them
IL126247A0 (en) Novel imidazolidine derivatives their preparation their use and pharmaceutical preparations comprising them
HUP9702241A3 (en) Use of 2-aminoindan derivatives and pharmaceutical compositions containing them
IL122173A0 (en) 3-amidochromanylsulfonyl (thio) ureas processes for their preparation their use and pharmaceutical preparations comprising them
IL119822A (en) Substituted chromanylsulfonyl (thio) ureas processes for their preparation their use in pharmaceutical preparations and pharmaceutical preparations comprising them
GB9501286D0 (en) Pharmaceutical compositions and preparations thereof
ZA961050B (en) Substituted benzenesulfonylureas and -thioureas processes for their preparation their use for the production of pharmaceutical preparations and pharmaceutical preparations containing them
NZ227594A (en) Human interleukin-1alpha and preparations thereof
AU6525096A (en) Modified human chorionic (beta-hcg) proteins and their medical use
ZA961314B (en) Substituted benzenesulfonylureas and -thioreas processes for their preparation their use for the production of pharmaceutical preparations and medicaments containing them
HUP9602220A2 (en) Substituted 4h-piranes and pharmaceutical preparations containing them
AU7352396A (en) Use of protein S-100b in medicines and medicines containing the protein S-100-b
AU625163B2 (en) Dihydrocaffeic acid derivatives and pharmaceutical preparations containing same